Non-dilutive capital is any funding that doesn't require you to give up ownership in your company. It includes grants, government programs, loans, tax credits, revenue-based financing, and prize money. Most founders default to equity — but equity is the most expensive capital long-term, because you pay for it forever in the form of ownership.

Important: Debt instruments, revenue-based financing, and government programs each carry legal, financial, and tax implications. This guide provides a conceptual overview. Before pursuing any of these options, consult with a qualified attorney, CPA, or financial professional who understands your specific situation.

Why non-dilutive capital matters

Equity is not free money. When you give an investor 20% of your company, you're giving them a share of every dollar you'll ever make — for as long as the company exists. At a $10M exit, that's $2M. At a $100M exit, that's $20M. Non-dilutive capital lets you fund operations, R&D, or growth without that permanent cost.

Many founders treat equity as the default and non-dilutive capital as the exception. The more useful framing is to ask: what capital do I actually need, and what's the cheapest, least-constraining source that fits?

Non-dilutive capital won't work for every company at every stage — some businesses genuinely need equity capital to grow. But most founders dramatically underutilize non-dilutive options, either because they don't know they exist or because they assume they don't qualify.

The main types of non-dilutive capital

Grants

Grants are money you receive without repaying and without giving up equity. They come from government agencies, foundations, and corporations. The key tradeoffs: grants are highly competitive, application processes are slow and often complex, and reporting requirements can be significant once you receive one.

The most relevant grants for early-stage startups:

  • SBIR and STTR — the federal Small Business Innovation Research and Small Business Technology Transfer programs fund early-stage R&D for science and technology companies. Phase I awards typically range from $150K to $300K; Phase II from $500K to $2M. These programs are for R&D-intensive companies — hardware, biotech, deep tech, software with significant technical risk. They're competitive but very meaningful for eligible companies. The process takes 6 to 12 months from application to funding.
  • State and local grants — many states and municipalities offer grants for early-stage companies, particularly in economic development priority sectors. These vary widely by location and change frequently.
  • Foundation grants — sector-specific foundations (health, climate, education, community development) fund startups aligned with their mission. Amounts range from small to significant.
  • Corporate innovation grants — large corporations run innovation grant programs, often in sectors where they want to build supply chain or technology relationships.

Loans and debt capital

Loans require repayment with interest — but you keep your equity. Debt makes sense when: you have some operating history or assets to collateralize, the interest cost is lower than the equity dilution you'd take, and your cash flow can support debt service.

  • SBA loans — the Small Business Administration offers several loan programs, including the 7(a) and 504 programs, that provide working capital, equipment financing, and real estate to small businesses. Favorable terms but require some operating history and creditworthiness.
  • Community Development Financial Institutions (CDFIs) — CDFIs provide financing to underserved businesses and communities, often with more flexible requirements than traditional banks. If you're in an underserved market or community, CDFIs are worth exploring first.
  • Venture debt — venture debt is debt designed for venture-backed startups, typically offered by specialized lenders alongside or after an equity round. It extends runway without additional dilution but requires existing investor backing and typically includes warrants.
  • Revenue-based financing — an investor provides capital in exchange for a percentage of future revenue until a fixed repayment cap is reached. No equity given up, no fixed monthly payment. Works well for companies with consistent, recurring revenue. Not a fit for pre-revenue or lumpy-revenue businesses.

Tax credits and incentives

Tax credits reduce what you owe, rather than providing upfront cash — but they're real money. The R&D tax credit (Section 41) allows eligible companies to claim a credit for qualified research expenses. Early-stage companies can often apply it against payroll taxes before they're profitable. Qualified Small Business Stock (QSBS) is a tax incentive for investors, not a direct capital source — but it can make your company more attractive to early investors by improving their tax position.

Many startups miss these because they file taxes without a CPA who specializes in early-stage companies. A good startup CPA will surface these opportunities.

Prizes and competitions

Startup pitch competitions, innovation challenges, and ecosystem awards offer non-dilutive capital in amounts that range from $5K to several hundred thousand dollars. The capital is rarely transformative, but at early stage it can extend your runway, and the credibility signal can help with fundraising.

Common mistakes founders make with non-dilutive capital

Not exploring it at all. The single biggest mistake. Most founders spend months on investor outreach without ever checking whether a grant or loan might be available. Even one week of research can surface meaningful opportunities.

Assuming they don't qualify. SBIR eligibility surprises many founders. CDFIs have flexible criteria. State grants reach more sectors than most people realize. Check before you assume.

Underestimating the timeline for grants. Grant applications take months to prepare and months to evaluate. If you need capital in 90 days, a grant is not the answer — but a grant in 9 months could materially change your next equity round.

Using revenue-based financing before your revenue is stable. RBF payments scale with revenue, which sounds flexible — but if your revenue dips, you're still making payments. Make sure your revenue profile supports the structure before signing.

Missing R&D tax credits. If you're doing any qualifying research and development, the credit is often available and significant. Talk to your CPA.

Which type is right for you

  • Pre-revenue, R&D-heavy (hardware, biotech, deep tech, software with significant technical risk): Grants and SBIR/STTR are your best starting point. Apply early — the timeline is long.
  • Early revenue, capital equipment needs: Equipment financing and SBA loans are worth exploring before equity.
  • Consistent recurring revenue (SaaS, services): Revenue-based financing can be an elegant alternative to equity for growth capital.
  • Any stage, with qualified R&D spending: File for the R&D tax credit. This is a common oversight.
  • Underserved communities or markets: CDFIs and CDFI-adjacent programs exist specifically for you — explore these before conventional lending.

When to get help

Grant applications are specialized and highly competitive. Working with a grant writer or consultant who has successfully navigated the programs you're targeting is worth the investment. Loans and RBF agreements have legal terms that need professional review. R&D tax credits require a CPA who understands startup tax strategy, not just general small business taxes. These are not DIY decisions at scale.